Milestone Pharmaceuticals Inc.
MIST
$1.34
$0.010.75%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -68.36M | -63.06M | -58.01M | -55.53M | -51.93M |
| Total Depreciation and Amortization | 724.00K | 695.00K | 647.00K | 647.00K | 645.00K |
| Total Amortization of Deferred Charges | 447.00K | 432.00K | 414.00K | 400.00K | 385.00K |
| Total Other Non-Cash Items | 13.40M | 10.21M | 8.00M | 7.99M | 7.90M |
| Change in Net Operating Assets | 2.65M | 2.68M | 5.84M | 6.12M | 9.13M |
| Cash from Operations | -51.14M | -49.04M | -43.11M | -40.38M | -33.87M |
| Capital Expenditure | -341.00K | -302.00K | -41.00K | -43.00K | -39.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -102.03M | 11.55M | 27.92M | 69.39M | 68.92M |
| Cash from Investing | -102.37M | 11.25M | 27.88M | 69.34M | 68.88M |
| Total Debt Issued | 75.00M | -- | -- | -- | -- |
| Total Debt Repaid | -11.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 102.18M | 82.95M | 46.55M | 274.00K | 238.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -251.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.57M | 2.57M | 2.57M | 0.00 | -47.00K |
| Cash from Financing | 179.74M | 85.53M | 49.12M | 274.00K | -60.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26.23M | 47.73M | 33.89M | 29.24M | 34.95M |